B

Biocytogen

96 employees

Biocytogen is a biopharmaceutical company that provides integrated solutions for antibody drug development.

Investor insights

Sectors invested in

Biotechnology1

Funding rounds participated in

$142M sweet spot round size

Most of their 1 investments are in rounds between $142M and $142M

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
Gene Targeting
Immuno-Oncology
In vivo study
Animal Production and Breeding
Immune-deficient mouse model
Antibody Research and Development
Fully human antibody mouse
Humanized Immune-oncology Checkpoint Mouse
Preclinical CRO
Health Care
Antibody discovery
Therapeutics
Animal Models
Preclinical Services

Date founded

2009

Investments made

多玛医药科技(苏州)有限公司 raised $142M on June 2, 2022

Investors: China Taiping Insurance (Australia Office), CMB International and Biocytogen

FAQ